BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5937026)

  • 1. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 3. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
    Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial purification of the binding activity for the long-acting thyroid stimulator in the human thyroid.
    Dirmikis S; Munro DS
    J Endocrinol; 1972 Nov; 55(2):xlv-xlvi. PubMed ID: 4636369
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity and specificity of blood and thyroid radio-iodine assays for TSH and LATS and inhibitory effect of corticosteroid.
    Sharard A
    N Z Med J; 1975 Jan; 81(531):21-2. PubMed ID: 1055309
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
    Hollows FC; Beaumont P
    Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
    [No Abstract]   [Full Text] [Related]  

  • 12. What is the antibody specificity of LATS?
    Fagraeus A; Jonsson J; el-Kabir DJ
    J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological mechanisms in thyrotoxicosis].
    Bradistilov S
    Vutr Boles; 1979; 18(2):9-16. PubMed ID: 380170
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system.
    Wood LC; Burger A; Peterson M; Ingbar SH
    Endocrinology; 1973 May; 92(5):1538-43. PubMed ID: 4695433
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of long-acting thyroid stimulator to pretibial myxedema.
    Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
    Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
    [No Abstract]   [Full Text] [Related]  

  • 18. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.
    Fedder G; Feltkamp TE
    Clin Exp Immunol; 1970 Jan; 6(1):167-8. PubMed ID: 4906525
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.